 Kenneth Krauter
Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polymorphism, Single Nucleotide | 17 | 2022 | 1880 | 1.030 |
Why?
| | Genome-Wide Association Study | 16 | 2022 | 1176 | 0.960 |
Why?
| | Genetic Variation | 6 | 2022 | 868 | 0.610 |
Why?
| | Mouth | 1 | 2017 | 69 | 0.570 |
Why?
| | Genetic Predisposition to Disease | 8 | 2022 | 2090 | 0.530 |
Why?
| | Substance-Related Disorders | 8 | 2020 | 942 | 0.490 |
Why?
| | Antisocial Personality Disorder | 5 | 2015 | 156 | 0.480 |
Why?
| | Genotype | 13 | 2019 | 1757 | 0.420 |
Why?
| | Myosin Heavy Chains | 2 | 2006 | 178 | 0.390 |
Why?
| | Metagenome | 1 | 2012 | 121 | 0.380 |
Why?
| | Alcohol Drinking | 4 | 2022 | 650 | 0.380 |
Why?
| | Marijuana Abuse | 4 | 2020 | 211 | 0.370 |
Why?
| | Saliva | 1 | 2012 | 188 | 0.370 |
Why?
| | Genetic Loci | 4 | 2022 | 262 | 0.350 |
Why?
| | Tobacco Use | 2 | 2022 | 60 | 0.340 |
Why?
| | Microbiota | 1 | 2017 | 648 | 0.340 |
Why?
| | Mental Disorders | 3 | 2021 | 889 | 0.290 |
Why?
| | Bacteria | 1 | 2012 | 725 | 0.270 |
Why?
| | Transcription Initiation Site | 1 | 2006 | 40 | 0.260 |
Why?
| | 5' Untranslated Regions | 1 | 2006 | 51 | 0.260 |
Why?
| | Chromosome Mapping | 7 | 2008 | 486 | 0.260 |
Why?
| | Phenotype | 10 | 2020 | 2784 | 0.250 |
Why?
| | Alternative Splicing | 1 | 2006 | 186 | 0.240 |
Why?
| | Multifactorial Inheritance | 2 | 2022 | 122 | 0.230 |
Why?
| | Alcoholism | 5 | 2020 | 710 | 0.230 |
Why?
| | Tobacco Use Disorder | 3 | 2020 | 234 | 0.230 |
Why?
| | Chromosomes, Human, Pair 18 | 1 | 2004 | 10 | 0.230 |
Why?
| | Genomics | 2 | 2020 | 631 | 0.230 |
Why?
| | Chromosome Inversion | 1 | 2004 | 17 | 0.230 |
Why?
| | Gene Duplication | 1 | 2004 | 62 | 0.220 |
Why?
| | Aggression | 2 | 2022 | 181 | 0.210 |
Why?
| | Receptors, Opioid, mu | 2 | 2015 | 52 | 0.200 |
Why?
| | Internationality | 1 | 2022 | 143 | 0.200 |
Why?
| | Conduct Disorder | 4 | 2015 | 193 | 0.190 |
Why?
| | Conserved Sequence | 2 | 1999 | 218 | 0.190 |
Why?
| | Multigene Family | 2 | 1999 | 190 | 0.190 |
Why?
| | Impulsive Behavior | 2 | 2015 | 113 | 0.180 |
Why?
| | Tobacco Products | 2 | 2019 | 98 | 0.180 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2022 | 119 | 0.170 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 363 | 0.170 |
Why?
| | Evolution, Molecular | 1 | 2004 | 429 | 0.170 |
Why?
| | Alleles | 7 | 2020 | 789 | 0.170 |
Why?
| | Minisatellite Repeats | 2 | 2019 | 38 | 0.170 |
Why?
| | Autistic Disorder | 1 | 2022 | 160 | 0.170 |
Why?
| | Rare Diseases | 1 | 2020 | 88 | 0.170 |
Why?
| | Genetic Linkage | 4 | 2008 | 294 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 2020 | 81 | 0.160 |
Why?
| | Muscle, Skeletal | 2 | 2006 | 1468 | 0.160 |
Why?
| | Genome, Human | 4 | 2020 | 347 | 0.160 |
Why?
| | Adolescent | 17 | 2022 | 17800 | 0.160 |
Why?
| | Cigarette Smoking | 1 | 2020 | 74 | 0.160 |
Why?
| | Feeding and Eating Disorders | 1 | 2020 | 103 | 0.160 |
Why?
| | Calcium-Transporting ATPases | 1 | 2018 | 34 | 0.150 |
Why?
| | Genetic Association Studies | 2 | 2021 | 339 | 0.150 |
Why?
| | Biological Specimen Banks | 1 | 2019 | 94 | 0.150 |
Why?
| | Twins | 4 | 2018 | 240 | 0.150 |
Why?
| | Humans | 34 | 2022 | 114045 | 0.150 |
Why?
| | Chromosomes, Human | 1 | 2017 | 39 | 0.140 |
Why?
| | alpha 1-Antitrypsin | 1 | 1998 | 102 | 0.140 |
Why?
| | Smoking | 2 | 2019 | 1382 | 0.140 |
Why?
| | Age of Onset | 1 | 2018 | 444 | 0.140 |
Why?
| | Male | 20 | 2020 | 55396 | 0.140 |
Why?
| | Psychological Trauma | 1 | 2017 | 54 | 0.140 |
Why?
| | Female | 20 | 2021 | 59324 | 0.130 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2016 | 34 | 0.130 |
Why?
| | Marijuana Use | 1 | 2018 | 167 | 0.120 |
Why?
| | Feces | 1 | 2017 | 372 | 0.120 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2017 | 485 | 0.120 |
Why?
| | Longitudinal Studies | 4 | 2016 | 2384 | 0.110 |
Why?
| | Gene Frequency | 3 | 2015 | 476 | 0.110 |
Why?
| | Genetic Testing | 1 | 2016 | 381 | 0.110 |
Why?
| | Receptors, GABA-A | 1 | 2014 | 82 | 0.110 |
Why?
| | Adult | 12 | 2022 | 30375 | 0.110 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 413 | 0.110 |
Why?
| | Veillonella | 1 | 2012 | 2 | 0.100 |
Why?
| | Actinomyces | 1 | 2012 | 4 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 771 | 0.100 |
Why?
| | Streptococcus | 1 | 2012 | 22 | 0.100 |
Why?
| | Marijuana Smoking | 1 | 2016 | 224 | 0.100 |
Why?
| | Quantitative Trait Loci | 2 | 2005 | 304 | 0.100 |
Why?
| | Chromosomes, Human, Pair 9 | 3 | 2006 | 42 | 0.100 |
Why?
| | Chromosomes, Human, Pair 3 | 3 | 2006 | 49 | 0.100 |
Why?
| | Membrane Transport Proteins | 2 | 2003 | 138 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 502 | 0.090 |
Why?
| | Haplotypes | 3 | 2007 | 448 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 182 | 0.090 |
Why?
| | Membrane Glycoproteins | 2 | 2003 | 429 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 722 | 0.080 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 757 | 0.080 |
Why?
| | Data Interpretation, Statistical | 3 | 2020 | 318 | 0.080 |
Why?
| | Peer Group | 1 | 2011 | 200 | 0.080 |
Why?
| | Sample Size | 2 | 2022 | 109 | 0.080 |
Why?
| | Educational Measurement | 1 | 2011 | 235 | 0.080 |
Why?
| | Teaching | 1 | 2011 | 209 | 0.080 |
Why?
| | Nerve Tissue Proteins | 2 | 2003 | 527 | 0.080 |
Why?
| | DNA | 4 | 2003 | 1350 | 0.080 |
Why?
| | Base Sequence | 3 | 2004 | 2114 | 0.080 |
Why?
| | Linkage Disequilibrium | 3 | 2020 | 245 | 0.070 |
Why?
| | Comorbidity | 3 | 2008 | 1447 | 0.070 |
Why?
| | Genome | 2 | 2006 | 269 | 0.070 |
Why?
| | Mice | 5 | 2006 | 14843 | 0.070 |
Why?
| | Risk | 2 | 2020 | 810 | 0.070 |
Why?
| | Learning | 1 | 2011 | 346 | 0.070 |
Why?
| | Receptors, Cannabinoid | 1 | 2006 | 13 | 0.070 |
Why?
| | Child | 6 | 2022 | 18401 | 0.070 |
Why?
| | Schizophrenia | 2 | 2022 | 412 | 0.070 |
Why?
| | Polymerase Chain Reaction | 3 | 2014 | 990 | 0.060 |
Why?
| | Students | 1 | 2011 | 499 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2015 | 3003 | 0.060 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 113 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2008 | 742 | 0.060 |
Why?
| | Carrier Proteins | 2 | 2016 | 694 | 0.060 |
Why?
| | Myoblasts | 1 | 2006 | 76 | 0.060 |
Why?
| | Protein Kinase C | 1 | 2007 | 271 | 0.060 |
Why?
| | Exons | 1 | 2006 | 301 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 273 | 0.060 |
Why?
| | Pan paniscus | 1 | 2004 | 5 | 0.060 |
Why?
| | Synteny | 1 | 2004 | 17 | 0.060 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2004 | 18 | 0.060 |
Why?
| | Centromere | 1 | 2004 | 42 | 0.060 |
Why?
| | Gene Library | 1 | 2004 | 114 | 0.060 |
Why?
| | Mouth Mucosa | 1 | 2003 | 79 | 0.050 |
Why?
| | Receptors, Dopamine D2 | 1 | 2003 | 86 | 0.050 |
Why?
| | Animals | 5 | 2006 | 31565 | 0.050 |
Why?
| | Loneliness | 1 | 2022 | 27 | 0.050 |
Why?
| | Europe | 1 | 2022 | 332 | 0.050 |
Why?
| | DNA Primers | 2 | 2003 | 508 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2006 | 801 | 0.050 |
Why?
| | Young Adult | 4 | 2018 | 10444 | 0.050 |
Why?
| | Middle Aged | 5 | 2019 | 26605 | 0.050 |
Why?
| | Cell Line | 1 | 2006 | 2629 | 0.040 |
Why?
| | Microsatellite Repeats | 3 | 2006 | 137 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 2002 | 131 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2006 | 1310 | 0.040 |
Why?
| | Child, Preschool | 3 | 2022 | 9114 | 0.040 |
Why?
| | Adolescent Behavior | 2 | 2005 | 486 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2022 | 203 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2783 | 0.040 |
Why?
| | Environment | 1 | 2000 | 333 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1998 | 152 | 0.040 |
Why?
| | United Kingdom | 1 | 2019 | 226 | 0.040 |
Why?
| | Risk Factors | 2 | 2022 | 8614 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2018 | 98 | 0.040 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 1998 | 70 | 0.040 |
Why?
| | Syndrome | 1 | 1998 | 330 | 0.040 |
Why?
| | Transcriptome | 1 | 2022 | 723 | 0.040 |
Why?
| | Species Specificity | 1 | 1998 | 541 | 0.030 |
Why?
| | Depressive Disorder, Major | 1 | 2020 | 301 | 0.030 |
Why?
| | Proteins | 1 | 1982 | 906 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2017 | 174 | 0.030 |
Why?
| | CD56 Antigen | 1 | 2016 | 34 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 312 | 0.030 |
Why?
| | Rats | 1 | 2004 | 4913 | 0.030 |
Why?
| | Anxiety | 1 | 2022 | 843 | 0.030 |
Why?
| | Potassium Channels | 1 | 2016 | 121 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 167 | 0.030 |
Why?
| | Interviews as Topic | 2 | 2007 | 575 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2015 | 126 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1131 | 0.030 |
Why?
| | Depression | 1 | 2022 | 1133 | 0.030 |
Why?
| | Regression Analysis | 2 | 2006 | 945 | 0.030 |
Why?
| | Gene Expression | 1 | 1998 | 1417 | 0.030 |
Why?
| | Pilot Projects | 1 | 2017 | 1360 | 0.030 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 2 | 2003 | 41 | 0.020 |
Why?
| | Colorado | 3 | 2007 | 4090 | 0.020 |
Why?
| | Risk-Taking | 1 | 2015 | 333 | 0.020 |
Why?
| | Macrophages | 1 | 1998 | 1259 | 0.020 |
Why?
| | Genetics | 1 | 2011 | 27 | 0.020 |
Why?
| | Liver | 1 | 1998 | 1633 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2016 | 1016 | 0.020 |
Why?
| | Demography | 1 | 2011 | 258 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1998 | 3498 | 0.020 |
Why?
| | Infant | 1 | 2021 | 7943 | 0.020 |
Why?
| | Plasmids | 1 | 1988 | 343 | 0.020 |
Why?
| | Exploratory Behavior | 1 | 2007 | 82 | 0.020 |
Why?
| | Factor Analysis, Statistical | 1 | 2007 | 257 | 0.020 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 230 | 0.020 |
Why?
| | Cohort Studies | 1 | 2015 | 4883 | 0.020 |
Why?
| | Genetic Markers | 1 | 2006 | 320 | 0.020 |
Why?
| | Diseases in Twins | 1 | 2006 | 174 | 0.020 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2005 | 56 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 6306 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2021 | 12521 | 0.020 |
Why?
| | Curriculum | 1 | 2011 | 813 | 0.010 |
Why?
| | Siblings | 1 | 2005 | 220 | 0.010 |
Why?
| | Lod Score | 1 | 2003 | 65 | 0.010 |
Why?
| | Receptors, Dopamine D4 | 1 | 2003 | 24 | 0.010 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2003 | 34 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1982 | 49 | 0.010 |
Why?
| | Gene Amplification | 1 | 2003 | 95 | 0.010 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2003 | 72 | 0.010 |
Why?
| | Genes | 1 | 1982 | 223 | 0.010 |
Why?
| | Nuclear Family | 1 | 2002 | 48 | 0.010 |
Why?
| | Statistics as Topic | 1 | 2002 | 291 | 0.010 |
Why?
| | Family Health | 1 | 2002 | 193 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2002 | 373 | 0.010 |
Why?
| | Psychology, Adolescent | 1 | 2000 | 63 | 0.010 |
Why?
| | Personality Disorders | 1 | 2000 | 67 | 0.010 |
Why?
| | Twins, Dizygotic | 1 | 2000 | 182 | 0.010 |
Why?
| | Child Behavior | 1 | 2002 | 220 | 0.010 |
Why?
| | Twins, Monozygotic | 1 | 2000 | 210 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2247 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2002 | 610 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2000 | 481 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2003 | 1690 | 0.010 |
Why?
| | Aged | 1 | 2016 | 18969 | 0.010 |
Why?
| | Models, Genetic | 1 | 2000 | 559 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2003 | 2764 | 0.010 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 1988 | 44 | 0.000 |
Why?
| | Biotechnology | 1 | 1988 | 41 | 0.000 |
Why?
| | Cloning, Molecular | 1 | 1988 | 522 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1988 | 287 | 0.000 |
Why?
|
|
Krauter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|